$4.04 $0.14 (3.6%)

04:00 PM EST on 11/13/19

Antares Pharma, Inc. (NASDAQ:ATRS)

CAPS Rating: 3 out of 5

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.

Current Price $4.04 Mkt Cap $636.6M
Open $3.90 P/E Ratio 0.00
Prev. Close $3.90 Div. (Yield) $0.00 (0.0%)
Daily Range $3.89 - $4.20 Volume 9,336,426
52-Wk Range $2.60 - $4.20 Avg. Daily Vol. 1,320,857

Caps

How do you think NASDAQ:ATRS will perform against the market?

Add Stock to CAPS Watchlist

All Players

186 Outperform
13 Underperform
 

All-Star Players

14 Outperform
3 Underperform
 

Wall Street

2 Outperform
1 Underperform
 

Top NASDAQ:ATRS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Rilac (77.15)
Submitted October 14, 2013

as of october 14th, Antares's product otrexup has been approved. following the news, Antares popped 5%. Otrexup's approval was an expected occurence hence the meager movement upward. Im expecting another runup in the short term. However im skeptic of… More

EclecticRecluse (80.01)
Submitted October 26, 2010

Extremely High Price for Sales

Recent Community Commentary

Read the most recent pitches from players about ATRS.

Recs

0
Member Avatar DonaldSS (< 20) Submitted: 7/7/2014 1:03:04 PM : Outperform Start Price: $2.66 NASDAQ:ATRS Score: -0.96

after CEO quick leave to smaller co. sales and announced uncoming events don't change.

Recs

1
Member Avatar Rilac (77.15) Submitted: 10/14/2013 2:54:24 PM : Outperform Start Price: $4.73 NASDAQ:ATRS Score: -93.39

as of october 14th, Antares's product otrexup has been approved. following the news, Antares popped 5%. Otrexup's approval was an expected occurence hence the meager movement upward. Im expecting another runup in the short term. However im skeptic of Oxtrexup's long term sales, so i wouldn't trade this for the long term.

Recs

0
Member Avatar louchios50 (< 20) Submitted: 10/2/2013 7:34:56 PM : Outperform Start Price: $4.32 NASDAQ:ATRS Score: -87.31

Research development m&a

Leaderboard

Find the members with the highest scoring picks in ATRS.

Score Leader

maniacdog

maniacdog (50.13) Score: +385.31

The Score Leader is the player with the highest score across all their picks in ATRS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
maniacdog 50.13 3/22/2016 Outperform 5Y $0.77 +436.69% +51.37% +385.31 0 Comment
vchelimella < 20 11/14/2017 Outperform 5Y $1.70 +143.53% +20.09% +123.44 0 Comment
wmtworker 80.69 11/13/2017 Outperform 5Y $1.76 +135.23% +19.75% +115.47 0 Comment
brogers146 70.54 12/28/2012 Underperform 5Y $3.75 +10.40% +119.80% +109.40 0 Comment
RUNNER71 70.44 11/20/2017 Outperform 1Y $1.81 +128.73% +19.62% +109.11 0 Comment
TheBestMarket 37.26 5/21/2012 Underperform 5Y $2.91 +42.27% +137.49% +95.22 0 Comment
PureStyle 30.06 5/21/2012 Underperform 5Y $2.91 +42.27% +137.49% +95.22 0 Comment
kaleidoscopic 67.61 11/18/2011 Underperform 3Y $2.60 +59.24% +152.86% +93.62 0 Comment
Joshdwashere < 20 4/4/2012 Underperform 3M $3.24 +27.78% +120.45% +92.68 1 Comment
DarrylHall 22.56 5/1/2012 Underperform 3W $3.16 +31.01% +118.44% +87.43 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ATRS.